Literature DB >> 16501993

Hemolytic uremic syndrome associated with pneumococcal pneumonia in Taiwan.

Yu-Hsuan Huang1, Tzou-Yien Lin, Kin-Sun Wong, Yhu-Chering Huang, Cheng-Hsun Chiu, Shen-Hao Lai, Shao-Hsuan Hsia.   

Abstract

Streptococcus pneumoniae ( S. pneumoniae ) has been associated with hemolytic uremic syndrome (HUS), which is an unusual but serious disease in childhood. We conducted a retrospective review of children aged less than 18 years with S. pneumoniae -associated HUS in northern Taiwan from January 2000 to June 2005. The demographic characters, clinical courses, and outcomes were analyzed. Seven children (three girls, four boys) with S. pneumoniae -associated HUS were studied. The median age at onset of HUS was 40 months (range: 25-60 months). The median duration of hospital stay was 36 days (range: 15-50 days). The interval between the onset of illness attributable to S. pneumoniae and the development of HUS was around 1-2 weeks. The onset of oliguria developed within 2 weeks after illness. Six patients required dialysis with median duration of 16 days. Three patients had leukopenia as the initial presentation. All seven patients had pneumococcal pneumonia complicating with empyema, and two of them received decortication via video-assisted thoracoscopic surgery. Between patients who needed dialysis or not, there was no significant difference in age, sex, duration of thrombocytopenia, incidence of extra-renal complications, such as hepatitis, pancreatitis, and hypertension, and length of hospital stay. The seven patients survived with normal renal function. HUS is a potentially fatal complication of S. pneumoniae infection. Clinicians managing patients with pneumococcal pneumonia with empyema accompanied by leukopenia should beware of the development of HUS. The long-term prognosis for recovery of renal function appears to be good in these patients in northern Taiwan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16501993     DOI: 10.1007/s00431-005-0041-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  RBC T activation and hemolysis: implications for pediatric transfusion management.

Authors:  K P Crookston; A P Reiner; L J Cooper; R A Sacher; M A Blajchman; N M Heddle
Journal:  Transfusion       Date:  2000-07       Impact factor: 3.157

2.  Prognosis of Streptococcus pneumoniae-induced hemolytic uremic syndrome.

Authors:  S Nathanson; G Deschênes
Journal:  Pediatr Nephrol       Date:  2001-04       Impact factor: 3.714

3.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

4.  Hepatocellular injury in Streptococcus pneumoniae-associated hemolytic uremic syndrome in children.

Authors:  C G Pan; H E Leichter; S L Werlin
Journal:  Pediatr Nephrol       Date:  1995-12       Impact factor: 3.714

5.  A review of acute renal failure in children: incidence, etiology and outcome.

Authors:  N E Moghal; J T Brocklebank; S R Meadow
Journal:  Clin Nephrol       Date:  1998-02       Impact factor: 0.975

6.  Clinical manifestations and molecular epidemiology of necrotizing pneumonia and empyema caused by Streptococcus pneumoniae in children in Taiwan.

Authors:  Yu-Chia Hsieh; Po-Ren Hsueh; Chun-Yi Lu; Ping-Ing Lee; Chin-Yun Lee; Li-Min Huang
Journal:  Clin Infect Dis       Date:  2004-02-27       Impact factor: 9.079

7.  Pneumococcus-induced T-antigen activation in hemolytic uremic syndrome and anemia.

Authors:  Joel B Cochran; Valerie M Panzarino; Lanne Y Maes; Frederick W Tecklenburg
Journal:  Pediatr Nephrol       Date:  2004-01-09       Impact factor: 3.714

Review 8.  Thrombotic microangiopathy: an atypical cause of acute renal failure in patients with acute pancreatitis.

Authors:  Alexandre Boyer; Karim Chadda; Amar Salah; Guy Bonmarchand
Journal:  Intensive Care Med       Date:  2004-04-07       Impact factor: 17.440

9.  Non-enteropathic hemolytic uremic syndrome: causes and short-term course.

Authors:  Alex R Constantinescu; Martin Bitzan; Lynne S Weiss; Erica Christen; Bernard S Kaplan; Avital Cnaan; Howard Trachtman
Journal:  Am J Kidney Dis       Date:  2004-06       Impact factor: 8.860

10.  Current status of antimicrobial resistance in Taiwan.

Authors:  Po-Ren Hsueh; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  6 in total

1.  Clinical features and outcomes of invasive pneumococcal disease in a pediatric intensive care unit.

Authors:  Hsiang-Ju Hsiao; Chang-Teng Wu; Jing-Long Huang; Cheng-Hsun Chiu; Yhu-Chering Huang; Jainn-Jim Lin; I-Anne Huang; Oi-Wa Chan; I-Jun Chou; Shao-Hsuan Hsia
Journal:  BMC Pediatr       Date:  2015-07-17       Impact factor: 2.125

2.  Community-Acquired Pneumonia in the Conjugate Vaccine Era.

Authors:  Derek J Williams; Samir S Shah
Journal:  J Pediatric Infect Dis Soc       Date:  2012-11-06       Impact factor: 3.164

Review 3.  Streptococcus Pneumoniae-Associated Hemolytic Uremic Syndrome in the Era of Pneumococcal Vaccine.

Authors:  Hemant S Agarwal; Samir Q Latifi
Journal:  Pathogens       Date:  2021-06-09

Review 4.  Clinical implications of pneumococcal serotypes: invasive disease potential, clinical presentations, and antibiotic resistance.

Authors:  Joon Young Song; Moon H Nahm; M Allen Moseley
Journal:  J Korean Med Sci       Date:  2013-01-08       Impact factor: 2.153

5.  Reappraisal of the etiology of extracorpuscular non-autoimmune acquired hemolytic anemia in 2657 hospitalized patients with non-neoplastic disease.

Authors:  Victor C Kok; Chien-Kuan Lee; Jorng-Tzong Horng; Che-Chen Lin; Fung-Chang Sung
Journal:  Clin Med Insights Pathol       Date:  2014-04-15

Review 6.  Streptococcus pneumoniae-associated hemolytic uremic syndrome.

Authors:  Lawrence Copelovitch; Bernard S Kaplan
Journal:  Pediatr Nephrol       Date:  2007-06-13       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.